European Companies Search Engine

Wordmark: “FEM JENAPHARM“ Euipotm 25 Dec 2008 European Union Intellectual Property Office (Trade Marks)

History

Text

Trade mark

Type Word
Name FEM JENAPHARM
Filing number 005713813
Trade mark status REGISTERED
Nice Classification

1: Chemicals used in industry, science and photography.

3: Soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices.

5: Pharmaceutical products and health-care products; dietetic substances adapted for medical use, food for babies, plasters, materials for dressings, disinfectants.

9: Apparatus for recording, transmission or reproduction of sound or images; magnetic and digital data carriers, compact discs.

10: Surgical and medical apparatus and instruments.

16: Printed matter, pamphlets, magazines, periodicals, newspapers, books, instructional and teaching material (except apparatus) in the field of medicine, lifestyle and healthcare.

38: Online provider services, namely the providing of access to discussion forums relating to medicine, lifestyle and healthcare; operating chat rooms; providing access to bulletin boards (online); transmission of information of all kinds (telecommunications services).

41: Education, providing of training in the field of medicine, lifestyle and healthcare; publication of books, periodicals and other printed matter, and associated electronic media (including CD-ROMs) in the field of medicine, lifestyle and healthcare; congresses, conferences and seminars in the field of medicine, lifestyle and healthcare.

42: Scientific and industrial research and development.

44: Medical, hygenic and beauty care; providing information on the Internet in the field of medicine, lifestyle and healthcare.

Filing date 13/02/2007
Registration date 07/02/2008
Expiry date 13/02/2027
Owners

Bayer Pharma AG

c/o Bayer Intellectual Property GmbH

Global Trademark Center (IPO-GTC)

Creative Campus Monheim

Alfred-Nobel-Straße 10

D-40789 Monheim am Rhein

Germany

The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Bayer Pharma AG, Berlin, Germany.